Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
Monday at 6 on WRAL: WRAL investigates why some veterinarians face minor consequences for fatal errors!
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
Next >
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
July 07, 2023
Tags
World Markets
Asia Markets
Science
From
CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
July 06, 2023
Tags
Alzheimer's disease
Science
World News
From
CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
June 13, 2023
Tags
Market Insider
Markets
Goldman Sachs BDC Inc
From
CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
June 09, 2023
Tags
U/S/ Economy
Health care industry
Eisai Co Ltd
From
CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
June 07, 2023
Tags
Biotech and Pharmaceuticals
Politics
U/S/ Economy
From
CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
May 15, 2023
Tags
Mad Money
ONEOK Inc
Chipotle Mexican Grill Inc
From
CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
May 12, 2023
Tags
U/S/ Economy
Eisai Co Ltd
Health care industry
From
CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
May 03, 2023
Tags
Starbucks Corp
Paycom Software Inc
Markets
From
CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
May 01, 2023
Tags
Epidemics
US Economy
US: News
From
CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
April 30, 2023
Tags
Eisai Co Ltd
U/S/ Economy
CVS Health Corp
From
CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
April 26, 2023
Tags
Business
Disease outbreaks
Health & Science
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Biotech and Pharmaceuticals
Health care industry
Eisai Co Ltd
From
CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
April 25, 2023
Tags
Science
Ionis Pharmaceuticals Inc
Breaking news
From
CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
April 06, 2023
Tags
US: News
Companies
Biogen Inc
From
CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
April 05, 2023
Tags
Eli Lilly and Co
Eisai Co Ltd
Health care industry
From
CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
March 22, 2023
Tags
Health & Science
Biotech and Pharmaceuticals
Breaking News: Business
From
CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
March 20, 2023
Tags
Health care industry
Biotech and Pharmaceuticals
Breaking news
From
CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
March 13, 2023
Tags
Pandemics
US Top News and Analysis
Politics
From
CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
March 06, 2023
Tags
Breaking News: Business
Health & Science
Business News
From
CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
February 23, 2023
Tags
US Top News and Analysis
Pandemics
Politics
From
CNBC.com News
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
February 17, 2023
Tags
Redfin Corp
Markets
Finance
From
CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
February 17, 2023
Tags
Health & Science
Breaking News: Business
Business News
From
CNBC.com News
Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
February 17, 2023
Tags
Epidemics
US Economy
US: News
From
CNBC.com News
Stocks making the biggest moves premarket: Kraft Heinz, Paramount, Airbnb, Tripadvisor and more
February 15, 2023
Tags
Taiwan Semiconductor Manufacturing Co Ltd
stocks
Breaking News: Markets
From
CNBC.com News
FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial
January 06, 2023
Tags
Politics
Pandemics
US Top News and Analysis
From
CNBC.com News
Stocks making the biggest moves midday: Mission Produce, Nutanix, Alphabet, Tesla and more
December 23, 2022
Tags
Tesla Inc
Chevron Corp
Biogen Inc
From
CNBC.com News
Stocks making the biggest moves premarket: Tesla, Nutanix, Meta and more
December 23, 2022
Tags
Mission Produce Inc
Eisai Co Ltd
Market Insider
From
CNBC.com News
Stocks making the biggest moves midday: CrowdStrike, Horizon Therapeutics, Petco and more
November 30, 2022
Tags
stocks
Breaking News: Markets
Stock markets
From
CNBC.com News
Stocks making the biggest moves premarket: Hormel, Petco, CrowdStrike and more
November 30, 2022
Tags
Stock markets
Breaking News: Markets
stocks
From
CNBC.com News
Stocks making the biggest moves midday: Apple, DraftKings, Biogen, Williams-Sonoma and more
November 28, 2022
Tags
DraftKings Inc
Exxon Mobil Corp
Conocophillips
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.